ChromaDex Corp., an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food and beverage, cosmetic and pharmaceutical industries, announced today that customer demand and unit sales of its recently launched BluScience line of dietary supplements have exceeded the Company's initial forecast and expectations during the first quarter ended March 31, 2012.
The nationwide launch of BluScience in retail outlets began in earnest in early 2012 whereby BluScience became available at a national drug store chain with more than 8,000 stores in the U.S., as well as at approximately 4,000 independent drugstores and pharmacies in the U.S.
In the first quarter of 2012, the initial launch achieved sales of more than 125,000 units of BluScience, more than 50 percent higher than the Company's initial forecast. Sales deductions for promotions and discounts related to the sale of BluScience product totaled $2,249,168 in the first quarter, resulting in net sales of BluScience products of $69,742. Higher than expected consumer demand for the BluScience line resulted in higher than expected promotional expenses.
As planned, promotional activities, discounted pricing and media programs were used to generate interest, and played a key role in the launch and initial consumer awareness of the product line.
Frank Jaksch, Co-Founder and CSO of ChromaDex commented, "ChromaDex made a strategic decision to significantly invest in our patented and proprietary pTeroPure by creating and launching the BluScience product line as well as financing the first human clinical study of pTeroPure. The results will provide an important independent clinical assessment of what we believe is an enormous opportunity with this product."